10th May 2022 | Pharma Updates
For COVID-19, Cipla released the 'RT Direct' Multiplex real-time PCR kit
Cipla Limited, in collaboration with Genes2Me Pvt. Ltd., announced the commercialization of the ‘RT-Direct’ multiplex COVID-19 RT-PCR Test kit in India and expanding its diagnostics portfolio to introduce more advanced & creative products.
Glenmark Pharma's psoriasis & dermatitis medication receives FDA approval
The US Food and Drug Administration (USFDA) has given the drug company preliminary approval for calcipotriene and betamethasone dipropionate foam.
JB Chemicals & Pharmaceuticals grown at pace of 29%
During the Financial Year 2021-22, JB Chemicals & Pharmaceuticals Ltd. has emerged as the fastest growing pharmaceuticals company among the top 25 corporations in the Indian Pharmaceutical Market, despite the ongoing COVID pandemic.
Drug network busted by NCB raid on Hyderabad net pharma firm
NCB stormed JR Infinity Pvt Ltd in Domalguda, an internet pharmacy that was reportedly organising the supply of psychotropic medications to users in the United States and other countries, arrested a man, and seized Rs 3.71 crore.
Lutathera and Pluvicto production temporarily halted, as per Novartis
As it addresses any quality issues detected in its manufacturing processes, the company has taken this measure out of an abundance of caution. Novartis is doing a comprehensive investigation into the matter and anticipates resolving the problems.
Launch of Roche Diabetes Care Pen needles ACCU-FINE for painless insulin delivery
Roche Diabetes Care India (RDC India) has introduced ACCU-FINE, a line of high-quality pen needles designed to make insulin delivery easier and painless for diabetics.
Europe's first SPAC focused on development of complex drugs
With aspirations to raise 150 million euros, Europe’s first “blank cheque” firm focused on acquiring companies that develop medications for the biotech and pharmaceutical industries.